381 related articles for article (PubMed ID: 8510751)
1. Crystal structure of cyclin-dependent kinase 2.
De Bondt HL; Rosenblatt J; Jancarik J; Jones HD; Morgan DO; Kim SH
Nature; 1993 Jun; 363(6430):595-602. PubMed ID: 8510751
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
[TBL] [Abstract][Full Text] [Related]
3. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.
Brown NR; Noble ME; Lawrie AM; Morris MC; Tunnah P; Divita G; Johnson LN; Endicott JA
J Biol Chem; 1999 Mar; 274(13):8746-56. PubMed ID: 10085115
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of cyclin-dependent kinase activation by phosphorylation.
Russo AA; Jeffrey PD; Pavletich NP
Nat Struct Biol; 1996 Aug; 3(8):696-700. PubMed ID: 8756328
[TBL] [Abstract][Full Text] [Related]
5. [The characterization of human cdc2 kinase and CDK2].
Yasuda H; Kamijo M; Ohba Y
Yakugaku Zasshi; 1993 Dec; 113(12):829-46. PubMed ID: 8301538
[TBL] [Abstract][Full Text] [Related]
6. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.
Rosenblatt J; Gu Y; Morgan DO
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2824-8. PubMed ID: 1532660
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation independent activation of human cyclin-dependent kinase 2 by cyclin A in vitro.
Connell-Crowley L; Solomon MJ; Wei N; Harper JW
Mol Biol Cell; 1993 Jan; 4(1):79-92. PubMed ID: 8443411
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
Pan ZQ; Amin A; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of cyclin A.
Brown NR; Noble ME; Endicott JA; Garman EF; Wakatsuki S; Mitchell E; Rasmussen B; Hunt T; Johnson LN
Structure; 1995 Nov; 3(11):1235-47. PubMed ID: 8591034
[TBL] [Abstract][Full Text] [Related]
12. Bound to activate: conformational consequences of cyclin binding to CDK2.
Radzio-Andzelm E; Lew J; Taylor S
Structure; 1995 Nov; 3(11):1135-41. PubMed ID: 8591024
[TBL] [Abstract][Full Text] [Related]
13. Use of an oriented peptide library to determine the optimal substrates of protein kinases.
Songyang Z; Blechner S; Hoagland N; Hoekstra MF; Piwnica-Worms H; Cantley LC
Curr Biol; 1994 Nov; 4(11):973-82. PubMed ID: 7874496
[TBL] [Abstract][Full Text] [Related]
14. Structuring cell-cycle biology.
Levine K; Cross FR
Structure; 1995 Nov; 3(11):1131-4. PubMed ID: 8591023
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
16. Activation of human cyclin-dependent kinases in vitro.
Desai D; Gu Y; Morgan DO
Mol Biol Cell; 1992 May; 3(5):571-82. PubMed ID: 1535244
[TBL] [Abstract][Full Text] [Related]
17. Critical role for the 310 helix region of p57(Kip2) in cyclin-dependent kinase 2 inhibition and growth suppression.
Hashimoto Y; Kohri K; Kaneko Y; Morisaki H; Kato T; Ikeda K; Nakanishi M
J Biol Chem; 1998 Jun; 273(26):16544-50. PubMed ID: 9632724
[TBL] [Abstract][Full Text] [Related]
18. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Brown NR; Noble ME; Endicott JA; Johnson LN
Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
Gu Y; Rosenblatt J; Morgan DO
EMBO J; 1992 Nov; 11(11):3995-4005. PubMed ID: 1396589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
